Strategy Asset Managers’s Bristol-Myers Squibb BMY Stock Holding History

Strategy Asset Managers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$206K	Buy	+3,391	New	+$198K	0.03%	258
2024 Q3	–	Sell	-10,744	Closed	-$687K	–	253
2024 Q2	$687K	Buy	+10,744	New	+$481K	0.15%	114
2023 Q3	–	Sell	-10,744	Closed	-$687K	–	232
2023 Q2	$687K	Buy	10,744 +685	+7%	+$45.9K	0.15%	114
2023 Q1	$697K	Buy	+10,059	New	+$709K	0.17%	102
2019 Q2	–	Sell	-82,625	Closed	-$3.94M	–	129
2019 Q1	$3.94M	Sell	82,625 -13,856	-14%	-$690K	0.89%	29
2018 Q4	$5.01M	Sell	96,481 -21,299	-18%	-$1.14M	1.22%	30
2018 Q3	$7.31M	Sell	117,780 -13,923	-11%	-$826K	1.49%	25
2018 Q2	$7.29M	Sell	131,703 -9	-0%	-$486	1.54%	26
2018 Q1	$8.33M	Buy	131,712 +10,190	+8%	+$656K	1.81%	23
2017 Q4	$7.45M	Buy	121,522 +17,337	+17%	+$1.08M	1.46%	25
2017 Q3	$6.64M	Sell	104,185 -2,782	-3%	-$162K	1.36%	25
2017 Q2	$5.96M	Sell	106,967 -12,080	-10%	-$657K	1.23%	29
2017 Q1	$6.47M	Sell	119,047 -12,777	-10%	-$701K	1.41%	27
2016 Q4	$6.42M	Sell	131,824 -3,104	-2%	-$170K	1.4%	27
2016 Q3	$7.28M	Buy	134,928 +4,983	+4%	+$320K	1.63%	25
2016 Q2	$9.56M	Sell	129,945 -13,096	-9%	-$925K	2.17%	12
2016 Q1	$9.14M	Sell	143,041 -35,175	-20%	-$2.22M	2.08%	17
2015 Q4	$12.3M	Sell	178,216 -5,988	-3%	-$396K	2.79%	4
2015 Q3	$10.9M	Sell	184,204 -2,858	-2%	-$181K	2.62%	4
2015 Q2	$12.4M	Sell	187,062 -2,835	-1%	-$187K	2.78%	4
2015 Q1	$12.2M	Sell	189,897 -16,977	-8%	-$1.06M	2.67%	3
2014 Q4	$12.2M	Sell	206,874 -3,421	-2%	-$193K	2.57%	6
2014 Q3	$10.8M	Buy	210,295 +5,438	+3%	+$272K	2.35%	11
2014 Q2	$9.94M	Buy	204,857 +184,340	+898%	+$9.08M	2.12%	18
2014 Q1	$1.07M	Sell	20,517 -1,465	-7%	-$78K	0.23%	73
2013 Q4	$1.17M	Buy	21,982 +15	+0.1%	+$764	0.26%	74
2013 Q3	$1.02M	Buy	21,967 +1,289	+6%	+$56.6K	0.24%	76
2013 Q2	$924K	Buy	+20,678	New	+$898K	0.22%	78

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Strategy Asset Managers's BMY Position: Q1 2026 in Review

Strategy Asset Managers opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 3,391 shares worth $206K. The stake represents 0.03% of the portfolio and ranks #258 among its holdings. This is a return to the name: Strategy Asset Managers previously reported a position in BMY as recently as Q2 2024.

Strategy Asset Managers first reported a position in BMY in Q2 2013 and has held it in 28 quarters since. The position peaked at $12.4M in Q2 2015. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Strategy Asset Managers held 3,391 shares of Bristol-Myers Squibb worth $206K as of Q1 2026.
Bristol-Myers Squibb was a new Strategy Asset Managers position in Q1 2026.
Bristol-Myers Squibb made up 0.03% of Strategy Asset Managers's portfolio in Q1 2026, its #258 holding.
Strategy Asset Managers first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 28 quarters since.
Strategy Asset Managers's Bristol-Myers Squibb position peaked at $12.4M in Q2 2015.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Strategy Asset Managers's 13F filing for Q1 2026, filed 12 May 2026.